Context Therapeutics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNTX research report →
About the company
Context Therapeutics Inc. , a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
- CEO
- Martin A. Lehr
- IPO
- 2021
- Employees
- 15
- HQ
- Philadelphia, PA, US
Price Chart
- Market Cap
- $60.06M
- P/E
- -1.54
- P/S
- 0.00
- P/B
- 1.19
- EV/EBITDA
- -0.14
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -59.95%
- ROIC
- -82.91%
- Revenue
- $0 · 0.00%
- Net Income
- $-36,123,615 · -35.17%
- EPS
- $-0.38 · 17.39%
- Op Income
- $-39,702,631
- FCF YoY
- 9.87%
- 52W High
- $3.62
- 52W Low
- $0.55
- 50D MA
- $1.83
- 200D MA
- $1.77
- Beta
- 1.75
- Avg Volume
- 1.88M
Get TickerSpark's AI analysis on CNTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 24, 26 | Pasternak Andy | other | 45,000 |
| Jun 24, 26 | Stacey Jennifer Evans | other | 45,000 |
| Jun 24, 26 | West Linda | other | 45,000 |
| Jun 24, 26 | Smith Karen L. | other | 45,000 |
| Jun 24, 26 | Walker Luke Nathaniel | other | 45,000 |
| Jun 24, 26 | Kantoff Philip W. | other | 45,000 |
| Feb 19, 26 | Levit Alex C. | other | 270,000 |
| Feb 19, 26 | Minai-Azary Jennifer Lynn | other | 275,000 |
| Feb 19, 26 | Chagin Karen Deborah | other | 290,000 |
| Feb 19, 26 | Lehr Martin A. | other | 815,000 |
Our CNTX coverage
Recent articles, reports, and earnings notes.
No research on CNTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CNTX report →Similar companies
Peers in the same neighborhood.